A University of Michigan-led study is giving new hope to people newly diagnosed with pulmonary arterial hypertension (PAH), a serious condition affecting the heart and lungs. Led by Dr. Vallerie McLaughlin of Michigan Medicine, the research points to a treatment approach that could help patients live longer, healthier lives. Learn how this breakthrough could change the future of PAH care.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.